bestseller

Global Alzheimer’s Drug Market: Trends, Opportunities And Forecasts (2015-2020) (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 Years, >65 Years Age; By Region; Global Dementia Market)

Executive Summary Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease. The Global Alzheimer’s Market is growing at a moderate rate over last five years on account of

Region : 030117793 | Price: 2900 | Report ID: 030117793
Executive Summary

Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease.

The Global Alzheimers Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population and escalating role of private and government bodies in empowering R&D measures to avoid degenerative disorders. During 2015-20, Global Alzheimer Disease Market is anticipated to grow at an increased rate on account of robust expansion plans of the increase in medical facilities. Moreover, increase in number of patients suffering from degenerative disorder is further anticipated to boost the Global Alzheimers market in the coming years.

According to Azoth Analytics research report, Global Alzheimers Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years; By Region; Global Dementia Market), global Alzheimers market is projected to exhibit a CAGR of over 8.54% during 20152020. On the basis of Reisberg Scale, market is categorized by seven stages of Alzheimer. Alzheimer is expected to be cured by Drugs; Exercise and Nutrition. Growth in Alzheimers Drug market is anticipated to grow in the next five years. Asia Pacific region dominated the revenue contribution share in 2014 and the region is forecast to continue its domination through 2020. Few of the leading companies operating in Global Alzheimers Disease Market include Axovant Sciences Ltd., Biotie Therapies, Acadia Pharmaceuticals, Novartis International AG and many more.

Scope of the Report

The report Global Alzheimers Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years; By Region; Global Dementia Market) analyzes the following aspects of global Alzheimers market:

Global Alzheimers Market Size, Share & Forecast
Segmental Analysis By Therapeutics, By Diagnostics and Biomarkers, By Imaging Sector, By Patient and By Drugs
Policy & Regulatory Landscape
Market Entry Strategies for Domestic/Foreign Players
Changing Market Trends & Emerging Opportunities
Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

1. To gain an in-depth understanding of Alzheimer disease and dementia market propelling globally.
2. To identify the on-going trends and anticipated growth in the next five years
3. To help industry consultants, drug and diagnostics manufacturers, vendors and dealers align their market-centric strategies
4. To obtain research based business decision and add weight to presentations and marketing material
5. To gain competitive knowledge of leading players
6. To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyers specific needs
1. Research Methodology

2. Alzheimers Disease Market Overview

3. Global Alzheimers Disease Market Outlook

4. Global Alzheimers Disease Market
4.1 By Therapeutics
4.2 By Diagnostics and Biomarkers
4.3 By Imaging Sector
4.4 By Disease Modifying Therapeutics

5. Global Alzheimers Disease Market Outlook-By Demographic (Age-Group)

6. Global Alzheimers Disease Market Outlook-By Drug

7. Global Alzheimers Disease Market Outlook-By Region

8. United States Alzheimers Disease Market Outlook
8.1 United States Dementia Market Outlook

9. Global Dementia Disease Market Outlook

10. Global Dementia Disease Market Outlook
10.1 By Regional Break-Up
10.1.1 Asia-Pacific Dementia Market Outlook
10.2 By Countries
10.2.1 Low Income Country -wise Break up
10.2.2 Top Ten Country-wise Break-Up
Australia Dementia Market Outlook
UK Dementia Market Outlook

11. Market Dynamics
11.1 Drivers
11.2 Challenges

12. Market Trends & Developments

13. Competitive Landscape
13.1 Sales Comparatives, Top 5 Companies
13.2 EBITDA Comparatives, Top 5 Companies
13.3 EBIT Comparatives, Top 5 Companies
13.4 PBT Comparatives, Top 5 Companies
13.5 PAT Comparatives, Top 5 Companies
13.6 Current Ratio Comparatives, Top 5 Companies

14. Company Profiling
14.1 Pfizer Inc.
14.2 Novartis International AG
14.3 Axovant Sciences Ltd.
14.4 Acadia Pharmaceuticals
14.5 Biotie Therapies

 

Research Methodology

 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.